Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2024-04-09 | Athena Countouriotis, M.D. joined our Board in December 2023. Dr. Countouriotis is co-founder, President, Chief Executive Officer and Chairperson of Avenzo Therapeutics, Inc., a private biotechnology company, since October 2022. ... 2023 Independent Director Compensation ... Athena Countouriotis, M.D. — Fees Earned or Paid in Cash, 213,378 Stock Awards, 213,378 Total. |
| 2025-04-08 | Athena Countouriotis, M.D. joined our Board in December 2023. Dr. Countouriotis is co-founder, President, Chief Executive Officer and Chairperson of Avenzo Therapeutics, Inc. She holds a B.S. in Physiology from UCLA and an M.D. from Tufts University School of Medicine. 2024 Non-Employee Director Compensation: Athena Countouriotis, M.D. received total compensation of $445,045. |
Data sourced from SEC filings. Last updated: 2026-03-05